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Introduction
M y B oss
Nearly all men die o f their remedies and not o f their illnesses. 
M o L lk R E , Le malade imaginaire, 1673
Recently I gave an educational talk to a group of nurses and aides at a 
nursing home and assisted-living facility about the dangers of hospital­
izing the frail elderly who live in long-term care. I am a certified med­
ical director (CMD), which means that I took courses and underwent 
additional extensive training to acquire a title that I can tack on after my 
MD. But most significantly, through my training and subsequent confer­
ences I mastered the regulatory minutiae and Medicare rules that impact 
much of geriatric medicine in the twenty-first century. I currently di­
rect several assisted-living facilities and retirement communities, as well 
as a nursing home. When I talk to the nursing staff, I usually focus on a 
pragmatic area of health care that will alter the way they care for their 
aged patients.
In this particular talk I distributed a handout enumerating the many pit­
falls elderly people may encounter in a hospital, highlighting the lack of ef­
ficacy and inherent dangers of hospital care in many circumstances. In fact, 
as I repeated multiple times in my talk, treating them in the facility itself in­
stead of a hospital is typically more humane and beneficial. The talk went
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over particularly well, because the nurses and aides understood the futility of 
hospitalization from their ample experience and enjoyed discussing the topic.
Later that night, however, I got word that one of the nurses who at­
tended the talk had sent a ninety-eight-year-old woman with dementia 
from the assisted-living facility to the hospital for confusion and weakness. 
At the hospital the woman became more confused and had to be sedated. 
Her arm had been poked with needles and she’d been made to undergo a 
head scan, something that must have been frightening to her. She was also 
exposed to potentially harmful medicines, dangerous infections, a high 
likelihood of treatment mistakes, and a hospital that pushes the most ag­
gressive care on elderly people despite a paucity of evidence to support that 
approach. As is common, they found a urine infection (something fairly 
ubiquitous in the elderly, to which much illness is ascribed) and they sent 
her back, not admitting her to the hospital where she may have been tied 
down and exposed to even more trauma.
I was not surprised that within hours of hearing my talk on hospitali­
zation, a nurse still insisted on sending this confused patient to the hospital 
for a fairly common medical issue, when I believed that the patient would 
have been better off staying put and having more gentle care and observa­
tion in familiar surroundings. I understood the many forces that conspired 
to force her to do something that likely she did not think was clinically nec­
essary or even prudent, something we will discuss extensively in this book.
I saw the patient a few days later. She was in a room with other resi­
dents with dementia, sitting in a chair, smiling, and clapping her hands. 
Some of the nursing aides were leading them in a sing-along. At that 
moment, freed from blood-pressure cuffs, blood sticks, X-ray machines, 
nursing-home regulatory rules, and handfuls of medicine, my patient was 
receiving perfect geriatric care. She was socializing, exercising, and using 
her brain. She was under no stress. She was not exposed to the sting of 
modern medicine. The dichotomy between her experience at the hospital 
and what I witnessed now was striking to me. Now she was in the hands of 
people who knew her and were making her life enjoyable, instead of at the 
mercy of people who dug into her elderly body trying to find problems and 
fix them. The former scenario is the very epitome of good geriatric care, 
while the latter is a geriatrician’s nightmare. The former is also cheap and 
humane, while the latter is horribly expensive, compromising the financial 
health of our Medicare system and turning patients into unwitting victims
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of unnecessary and futile aggressive treatment. Unfortunately, it is the lat­
ter that is becoming the norm in the treatment of geriatric patients. And 
the most tragic part is that Medicare itself is financing and encouraging 
that expensive and ineffective approach.
With this book I hope to demonstrate how our health-care system is fail­
ing our oldest and frailest Americans, and how that failure is inextricably 
tied to Medicare’s philosophy and payment structure. My critique is part of a 
larger social debate that is developing about the goals of modern medicine in 
particular and the health-care system in general. Many patients, physicians, 
other health-care professionals, and health-care organizations—including 
unions, foundations, patient-safety organizations, and politicians—are be­
coming increasingly concerned about the principles and practices that esca­
late health-care costs and put patients at risk.
Over the past few years I have read dozens of books warning of the 
perils of overtreatment for patients of all ages, especially those who are 
old and frail. Shannon Brownlee’s best-selling book Overtreatment focuses 
on the general problem of unnecessary and unsafe medical treatments. 
Books by Nortin Hadler {The Last Well Person and Rethinking Aging) and 
H. Gilbert Welch (Overdiagnosed) explore the medical facts regarding 
many widely accepted tests, medicines, and procedures. Richard Deyo’s 
book Watch Your Back zeros in on one particular aspect of the edifice of 
overtreatment—unnecessary and dangerous treatments for the back pain 
that cripples millions of Americans—while Gayle Sulik’s Pink Ribbon 
Blues demonstrates how the medical establishment can distort health in­
formation with detrimental results. In 2015, Stephen Schimpffs Fixing 
the Primary Care Crisis explored how current strategies have thwarted the 
doctor-patient relationship, and how enabling better doctor-patient dis­
course at the primary-care level will lead to better care, lower cost, and 
higher satisfaction with the system. As I finish this book, I have read Being 
Mortal, surgeon Atul Gawande’s eloquent plea for a reconsideration of fu­
tile treatment at the end of life, and Angelo Volandes’s book The Conversation, 
which tries to help patients and physicians navigate discussions that can 
lead to less aggressive and more appropriate care during terminal illness.
My book is a part of this larger discussion. Its subject is the crisis in pri­
mary and geriatric care. I consider this vexing issue by exploring how one 
of our most critical health-care programs, Medicare, has become one of the 
most influential proponents of the kind of aggressive, specialist-oriented
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care that is driving up health-care costs and increasing the suffering of the 
elderly and their families. After decades of practice and reflection, I have 
come to this conclusion far more in disappointment than anger (although 
I certainly have some of both).
In fact, I love the idea of Medicare. I studied it as a history student at 
Brown University. I believe in its central role in our health-care system. 
Its creation has saved countless lives and improved the quality of life for 
all elderly Americans. It provides millions of Americans who would oth­
erwise lack health-care insurance with access to health-care services. As 
a financing mechanism it is far more efficient than the private insurance 
that has been one of the primary cost escalators in our system and which 
encourages fragmentation of, as well as aggressive and inappropriate care 
for, millions.
But Medicare is far more than a financing mechanism that brings health 
care to the elderly. As we will see in this book, the Centers for Medicare 
and Medicaid Services (CMS) promulgates policies and practices that de­
termine the forms of care it will allow and subsequently what kind of care 
the elderly receive, where they receive it, and who delivers that care. Medi­
care also serves as a model that many other health insurance companies 
follow. For instance, once Medicare sets its rates, enforces rules, or imple­
ments new programs, most commercial insurances mimic those changes. I 
have been immersed in the intricacies of Medicare policies and politics for 
the past twenty-five years. In the course of my career I’ve read the debates 
in Congress and among the intellectual elites about its future, listened to 
politicians and academic giants dissect its flaws, studied Medicare’s own 
solutions to its woes, and read how the lay press perceives its impending 
collapse and how it may be saved.
Most important, as an internist whose practice has focused on geriat­
rics, caring for the old, every day I live under the shadow of CMS’s rules, 
regulations, and reimbursement. What I have come to understand is that 
Medicare has not escaped the imperatives and priorities of the broader 
American health-care system. Medicare, which Congress created in 1965 
to provide health insurance for the elderly, inherited these imperatives and 
priorities and has—sometimes unwittingly, sometimes deliberately, some­
times out of sheer exhaustion—reinforced these priorities. Some of those 
who are fighting for a more rational health-care system brandish as their 
slogan “Medicare for All.” As a financing mechanism for a tax-supported
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national health-care system, this may be a wise idea. As a model of policies 
and practices that guide the delivery of health-care services to the elderly, 
it needs to be examined critically. We need to think about the kinds of 
services and priorities that CMS promotes, whether for the elderly, or po­
tentially for every American, before simply superimposing the Medicare 
system on a more general model of care.
Because I am a geriatric physician, Medicare controls a huge part of 
my life. It pays the bills and sets the rules of my practice. I cannot charge 
more or less than it dictates, I must write notes as it instructs, and even my 
interactions with families and patients are controlled by its regulations. 
The problem is that Medicare has been deeply influenced by the kind of 
contemporary medical thinking that equates aggressive, specialized care 
with good care, even for patients very advanced in years. That lore has 
taken root in how Medicare treats its seniors, and prompts our financially 
strapped national insurance to thrust a large amount of its budget into fu­
tile efforts to keep people alive at the end of their lives with the full gamut 
of technologically advanced medical services. As we will discuss further 
in this book, physicians in the United States have been taught and “incen- 
tivized” to deliver this kind of care. The media has pushed it, and many 
patients—even some of the oldest—are fueled in their misconception by 
doctors, the press, drug companies, and the very Zeitgeist of the American 
way of life to believe the false credo that more is better. Others are pushed 
to be aggressive by Medicare’s rules. Hovering over everything is the poli­
tics of perception: when Medicare curtails any service, people on both sides 
of the political aisle cry foul, insinuating that any restriction in Medicare’s 
quest to do everything for everyone is akin to letting our elderly die.
The sad reality is that Medicare has become an active partner in our 
national obsession with illness. Americans think they are sick and perpet­
ually search for cure and resolution, especially as they age.1 Their quest 
for medical answers to the ravages of aging fills them with a heavy dose of 
stress, merely exacerbating their own decline and dragging the health-care 
delivery system down with them.2 The public—from patients and their 
families to doctors, experts, politicians, and journalists—believe that with 
enough perseverance, our health-care delivery system is capable of virtu­
ally anything, even reversing the ravages of aging. From that perch of false 
information, and with incentives pushing them, many patients and their 
families plunge into a sea of aggressive care, often unwittingly.
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One could argue that the youngest and most vibrant Medicare recipi­
ents, many of whom still work and engage in vigorous activity, may benefit 
from aggressive care. Plenty of people dispute this claim, and in some cases 
I agree with them, but I will not address that debate in my book. Most of 
my subjects are the oldest and sickest of our Medicare patients, and among 
these, many have dementia, live in assisted-living facilities and nursing 
homes, and often utilize excessive Medicare resources without deriving 
any benefit from their “thorough” care. To what would actually help the 
very old—compassionate care delivered in their own homes—Medicare 
all too often turns a blind eye, reluctant to assist those who seek dignity and 
comfort in their quest to stay healthy and active in their later years without 
being driven into the claws of medical excess.
A century or so ago US medicine evolved from a field dominated by 
charlatans who dispensed potions and false promises to a distinguished 
profession led by well-trained practitioners versed in the science of med­
ical care. (See Paul Starr’s The Social Transformation of American Medi­
cine for an excellent discussion of the history of health care in the United 
States.) Unfortunately, as medical science advanced, so too did the percep­
tion that science and technology could cure everything. More machines, 
drugs, procedures, and tests sprouted across our medical landscape, and 
the belief spread that all illness, even the illness of age itself, would fall 
prey to the ingenuity of medicine. People no longer had to get sick and 
die. By utilizing all our brilliant resources, by assaulting disease at its 
roots, we could halt the aging process and begin a trek toward immor­
tality. None of that proved to be true, but the public started to believe it. 
More specialists emerged, promising more narrowly focused care. More 
scans, more drugs, and bigger and more sophisticated hospitals prolif­
erated, growing from an errant belief. And into this landscape stepped 
Medicare, the most expansive leap into health-care delivery ever enacted 
by the US government.
President Truman was the first to attempt creating a comprehensive, 
inclusive health-care system, but his effort was ultimately thwarted by the 
perception, despised in the United States, that his reform would lead to 
rationing of care.3 Similar arguments also destroyed President Clinton’s 
attempted reform efforts and emasculated President Obama’s Affordable 
Care Act (ACA). When President Johnson pushed through Medicare in 
1965, he too met vigorous opposition from medical and community groups
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that feared a loss of autonomy for patients and doctors and envisioned 
Medicare sparking a socialized medical system that would compromise 
medical standards in the United States, lower the level of excellence in 
research and care, and lead ultimately to rationing. The AMA (Ameri­
can Medical Association) especially fought to stop Medicare’s enactment,4 
something I researched as part of my senior thesis at Brown University. I 
pored through AMA journals, in which physicians and medical experts 
predicted doom if Medicare became reality, and I read contemporary ar­
ticles in newspapers and magazines that mirrored much of the debate we 
are hearing now regarding health-care reform and its potential to destroy 
quality through rationing. The AMA actually proposed its own more pri­
vate insurance plan for the elderly called Eldercare even as it threatened to 
boycott Medicare and not participate. When it finally did agree to endorse 
Medicare, the AMA had forced enough concessions from the government, 
especially with regard to keeping doctors and hospitals strong and inde­
pendent, that it actually gained financially from the plan’s enactment.5 It is 
not ironic, then, that the AMA is one of many medical organizations now 
fighting to keep Medicare intact and largely unchanged, despite its initial 
opposition to the plan. Doctors and hospitals thrive in Medicare, as Medi­
care finances the most advanced and aggressive medical care for all elderly 
Americans. At Medicare’s birth such a philosophy seemed both sound and 
affordable. But the medical profession, and the population it serves, has 
changed dramatically since 1965.
When Medicare was envisioned, there were far fewer elderly in the 
United States requiring health care. The population over age sixty-five, 
before Medicare started caring for them, accounted for about 8 percent of 
the population, or 12 million people. By 2009 the elderly represented 12.8 
percent of the population, nearly tripling to 35 million people. By 2050 the 
elderly are expected to be 20 percent of the US population, exploding to 
88.5 million people. Among the elderly, the very old are proportionately 
growing faster than any other group. Those over eighty are projected to 
he the most populous age group by 2050, representing 7.4 percent of the 
population, or 32.5 million people.6 Medicare must now serve more and 
older people than its framers anticipated.
The number of Medicare recipients with diseases of dementia, such as 
Alzheimer’s disease, has also ballooned since the insurance’s inception. 
At the time Medicare was scripted, Alzheimer’s was not even identified
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as a medical condition, and the cost of dementia care was minimal. But 
as that reality has changed, the cost of such care has accelerated rapidly. 
Currently 5 million Americans are diagnosed as having Alzheimer’s, and 
that number is expected to reach 7 million by 2025. The cost of caring 
for those people is estimated at $203 billion, over half of which is paid by 
Medicare. The total cost of care is expected to reach $1.2 trillion by 2050.7 
In 2015 Medicare spent $112.7 billion caring for people with dementia, 
constituting almost 20 percent of total expenditure. The cost per recipient 
incurred by Medicare is $21,585 annually for those with dementia, and 
$8191 for those without.8 Currently 61 million Americans care for their ill 
or disabled family members, many of whom have dementia, spending an 
average of eighteen hours a week doing so. A quarter of the baby-boom 
generation provides care for an aging parent.9 Because Medicare pays so 
little to help care for people with dementia in their homes, often families 
have to hospitalize their loved ones out of desperation, something that es­
calates Medicare costs needlessly. Medicare’s framers never considered the 
consequences of dementia and other debilitating diseases of aging on its 
model of care.
In addition to the sheer numbers and illnesses of its clients, Medicare’s 
expenses are impacted by changes in health-care delivery since 1965. We 
are now a medical society dominated by specialists, high-priced tests and 
procedures, and very expensive hospitals. Compared to 1965, Medicare pa­
tients now have at their disposal massive amounts of medical technology 
that society has embraced as being the most thorough means of assaulting 
illness and disability. In addition, because from its inception Medicare has 
focused on and finances hospital care above all else, every American over 
age sixty-five has access to Medicare A, which pays for hospitalization. The 
hospital is free for all elderly Americans after a single deductible (approxi­
mately $1,000), a cost that is usually paid by their secondary insurance. The 
hospital remains the center of care for the elderly, the place where older 
Americans must go when they are too sick to stay at home, when they seek 
Medicare’s payment for round-the-clock nursing and rehabilitation ser­
vices, and when they want Medicare to pay for certain invasive treatments 
such as IV fluids and antibiotics. Under Medicare’s current payment struc­
ture, the frail elderly are pushed into the hospital even when they would 
prefer to stay at home, despite the peril and price tag that such a journey 
entails.
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Medicare B covers most other services, including doctor’s visits, tests, 
procedures, and certain physical therapy. Americans have to pay a small 
premium to enroll in Medicare B, and well over 90 percent of Americans 
have done this. After charging patients a nominal deductible (approxi­
mately $150), Medicare B will pay for 80 percent of all services. The vast 
majority of Americans purchase secondary insurance that will pay the 20 
percent of cost that Medicare does not cover. Thus, most elderly Ameri­
cans, after paying their annual premiums and secondary insurance cost, 
receive all medical services without charge. Medicare B will not pay for 
meaningful health care in the home, for home health aides, or for med­
icines. Often when they get too ill, patients will need to use Medicare A, 
and that typically requires a stay in the hospital. In its current form, Medi­
care puts no limits on expensive tests and specialty visits, encourages hos­
pitalization for those most ill, and does not contribute to more palliative 
care in the home.
The newest incarnation of Medicare, which was enacted in 2006, 
Medicare D, covers a large part of medication costs for those recipients 
who pay an annual fee. Already by 2010 the program was costing the fed­
eral government $62 billion, or 12 percent of the entire Medicare budget.10 
Congress made two crucial errors in enacting part D. First, it underesti­
mated the cost of the program and how widely it would be used. Second, 
it explicitly prohibited the government from negotiating with pharma­
ceutical companies to create a formulary of reasonably priced medicines, 
a strategy that other federal agencies, such as the Department of Veterans 
Affairs (VA), have employed to keep costs down. As a result, Medicare 
D recipients can choose the most expensive brand-name drugs with lit­
tle restriction and with no competitive price reductions.11 In a medical 
landscape cluttered by high-priced drugs that promise the elderly mirac­
ulous results, Medicare D has become an albatross that strangles the entire 
Medicare system.
The result of Medicare’s failure to adjust as the world has changed 
around it has taken a toll on the US economy, placing Medicare under 
the political microscope as one of the primary drivers of our budget defi­
cit. Although over the past few years the rate of growth of Medicare has 
slowed, it is still growing and becoming more costly. The financial num­
bers are staggering. Medicare cost the government $7.1 billion in 1970, $35 
billion in 1980, $109.7 billion in 1990, $219 bill ion in 2000, and $550 billion
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in 2012.12 The cost of care escalates for the oldest of Medicare’s recipients. 
In 2011 the per capita cost among Medicare recipients over eighty-five 
was nearly double the amount spent on younger people ($13,788 versus 
$7,859). The cost of those who reported they were in poor health was 
even higher, with the costliest 5 percent of beneficiaries accounting for 
40 percent of all Medicare spending. Many of these people are very old, 
dealing with dementia, and living in institutions.13 Many are forced into 
the hospital and encouraged to undergo tests and procedures that are both 
costly and ineffective. No amount of money can fix their aging bodies, 
and much of the money spent for their care likely causes more harm, as 
we will show. A 2013 Washington Post article highlighted that in the US 
medical system, 1 percent of patients exhaust 21 percent of total health­
care costs, at a price of $88,000 per person per year.14 Clearly the sickest 
Americans, many of whom are not likely to improve despite the money 
spent on their care, are taxing our system, often for reasons related to 
Medicare’s payment structure.
Can thorough and aggressive medical care help prolong life and im­
prove its quality for our oldest patients? The very idea that overutilization 
of health care leads to improved outcomes has been debunked repeatedly, 
something we will explore extensively in this book.15 We in the geriatric 
field know it innately; our very souls are watered by the knowledge that 
more is less, and that aggressive care can be deleterious care. When one 
studies the literature it becomes apparent that there is a paucity of data 
specifically relevant to our oldest patients, many of whom have multiple 
illnesses and are on a plethora of medicines.16 So, often erroneously, we ex­
trapolate data from younger patients, or we accept assumptions that have 
been hammered into our heads, that all diseases should be eradicated, and 
that our society is blessed with an abundance of life-saving treatments. In 
fact, as little as 15 percent of what doctors do is backed up by valid evi­
dence that supports its efficacy.17 And thus we send our oldest and frailest 
patients on a journey that is costly both to them and to society with little 
evidence to back us up.
Many books and studies have explored the false notion that aggres­
sive care leads to improved outcome in the elderly, and I have been lucky 
enough to be able to use them as resources.18
But the crux of my argument flows from my own experience and that of 
my colleagues. While medical literature can help guide us to make sensible
My Boss 11
decisions, most of us who practice medicine every day have become skepti­
cal as to the validity of what we read in journals. We know that many stud­
ies are financed by pharmaceutical companies and special interest groups, 
that the overly screened subjects accepted into such studies look nothing 
like the more complicated patients we see every day, and that the conclu­
sions are subject to many interpretations. We also have seen studies touting 
the benefits of a drug or treatment, only to be completely reversed some 
years later. When I was a medical student it was considered standard care 
to treat women with estrogen after menopause, and it was deemed dan­
gerous to treat patients with failing hearts (congestive heart failure) with 
a class of drugs called beta-blockers. Studies and literature supported such 
suppositions, academic physicians assured us of their validity, and clini­
cal pathways enshrined such beliefs as gospel. Well, some years later, new 
studies emerged, and now it is bad practice to give women estrogen after 
menopause and to deny patients with congestive heart failure beta-blocker 
drugs.
There are so many examples where science and dogma are turned on 
their heads, leaving us doctors to ascertain reality for ourselves. I have seen 
academics and physicians interpret a single study to argue opposite points, 
showing me that the literature is far less scientific and objective than we are 
led to believe. Finally, few large studies focus on the frail elderly among 
their subjects, and those are the people most vulnerable to the sting of ag­
gressive care. Hence, while I frequently cite the literature that is out there, 
in this book I rely on my own experience as a geriatric doctor to reach 
many of my conclusions.
My own career as a doctor has demonstrated to me the futility of pur­
suing excessively thorough care for many elderly patients, while revealing 
to me the wall Medicare has enacted that prevents us from offering our 
patients a more sensible and economical alternative. My career started in a 
small town called Taunton, and that two-year experience opened my eyes 
wide to what is wrong with our current Medicare system. Taunton was 
a world unto itself. Small and isolated in the bog-filled serenity of south­
eastern Massachusetts, with a population made up of many ethnic Por­
tuguese who had been there for generations, Taunton was home to large 
numbers of working-class families who rarely moved away. And although 
they lived half an hour away from the medical meccas of Boston and Prov­
idence, most of my patients refused to travel that far; they preferred little
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Morton Hospital with six beds in a room and their local doctors. They 
trusted us, they listened to us, they respected us, and they treated us with 
unfettered kindness.
In Taunton in those days my patients understood the limits of medical 
intervention. They did not chase medical miracles or rely on the promises 
made by aggressive doctors, pharmaceuticals, and the press. Compared to 
the well-educated enclaves in which I practiced subsequently, my Taunton 
patients understood the aging process and based their decisions on com­
mon sense and dignity. These were the smartest group of patients with 
whom I have ever worked.
Often on my way home to East Providence I made home visits, where 
I was greeted with a hug and a smile, never a list of demands or piles of 
Internet articles. One day I stopped to see an elderly Portuguese woman 
with moderate dementia. She lived in a two-story colonial house that was 
older than she was, cuddled upstairs in a small bedroom with a hospital 
bed and a large, metal lifting mechanism (called a Hoyer Lift) next to some 
old upholstered furniture and a nightstand. Grandkids ran in and out, up 
and down; any number of them visited the house regularly. Some children 
lived in the house, many others lived nearby, all congregated here on the 
days I arrived.
Whenever I saw Mrs. A. she smiled and held my hands gently. She 
spoke a few words in Portuguese that her daughters translated for me, 
typically general pleasantries rather than anything of particular substance. 
I would listen as she or her daughters expressed any concerns. We re­
viewed her medicines, stopping any that seemed no longer needed or not 
beneficial. I took her blood pressure, and listened to her heart and lungs, 
a step required of all of us in the medical field. After my brief visit Mrs. 
A. thanked me profoundly, typically with a kiss on the cheek, after which 
her daughter pushed something on me, such as homemade sweet bread or 
a box of candy. I always left elated, although part of my brain questioned 
the significance of the service I provided or the wisdom of Medicare paying 
me for doing so little.
One dreary winter day I stopped by her house at the behest of one of 
her daughters. After our traditional greetings, I noticed that Mrs. A.’s eyes 
were yellow. She was scratching herself, something that proved to be her 
daughter’s main concern that day. She still smiled, and the stomping and 
laughter of children had not faded one bit. I examined her. She had a large
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liver protruding down to her groin, and she was severely jaundiced. I was 
concerned.
I took her daughter aside. “Your mom has something serious going on,” 
I told her. “She has jaundice. We may need to do some tests.”
The daughter smiled. “My mother is eighty-five years old,” she 
said. “If we could just give her something for her itching. She seems so 
uncomfortable.”
“But it could be treatable,” I went on. “Maybe it’s a gallstone. Or a re­
sectable cancer.”
The daughter put her hands on my shoulder. “She is eighty-five,” she 
repeated, with a smile that shined with absolute serenity and conviction. “I 
don’t want to put her through all those tests. But I would like her not to be 
so uncomfortable, if that is even possible. You tell us what is best.”
I nodded and gave her both an antihistamine for the itching and some 
Questran powder that worked particularly well for the jaundice itch (al­
though very constipating, as I warned the daughter). The daughter stepped 
to another room for a moment, and returned with a bottle of wine in a 
woven basket casing. “Take this,” she said. “And thank you. My mother 
feels so much better after your visits. And so does the whole family. Thank 
you so much.” It was as if the daughter knew that this would be my final 
visit.
Mrs. A. died many months later, comfortable and surrounded by her 
family.
If only all of our country followed the sensible script of Mrs. A. and 
many of my other patients in Taunton in those days. She charged Medi­
care no more than the cost of a few of my visits and some rented medical 
supplies. Probably less than a thousand dollars. And all this for the perfect 
ending to a relatively stress-free aging process.
Contrast that to an adult child who chided me for not checking her 
eighty-plus-year-old dad’s PSA blood test, and when she did bring him 
to a urologist at a major academic medical center to perform that test, 
and it showed that he had prostate cancer, she graced me with several 
instructional notes about how his new squadron of doctors were actually 
doing something for her dad, rather than neglecting him as I did. After a 
multitude of tests, biopsies, scans, treatments, and visits to the most bril­
liant minds at a renowned hospital far from his home, my once carefree 
patient became consumed by stress, and finally did die, of a heart attack,
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not anything to do with his PSA. After which his child said: “At least I 
know that they were thorough in their treatment of my dad and we did 
all we could to get him well.” She would have had it no other way. Tens 
of thousands of dollars later, dollars paid by Medicare, her father died 
of stress, likely precipitated by the very misguided pursuit that Medicare 
financed.
In any given week I may encounter a patient or family member who 
demands unreasonable tests, treatments, hospitalizations, specialist visits, 
and impossible answers for the ravages of aging in patients little different 
from Mrs. A. Instead of loving kindness and an acceptance of aging, they 
conjure incessant stress for themselves, their loved ones, and me and my 
staff by trying to achieve the impossible. On any given day I will encounter 
many more patients and families who prefer to live the life of Mrs. A., be 
kept comfortable, be on fewer medicines, and have fewer tests, but who are 
pushed reluctantly in the direction of aggressive care by a medical system, 
a society, and an insurance that enables and encourages excess.
Whenever I hear about proposals to ameliorate our society’s excessive 
consumption of medical care, I find that many reformers ascribe blame to 
doctors who both profit from and relish a health-care system that is fueled 
by excess. Such reformers concoct ingenious theories that contend that by 
tying physician salary to performance and not to fee-for-service somehow 
patients will no longer be allowed to abuse services. But in my career I 
have seen it from a different angle. Many primary-care doctors do their 
best to stop older patients from pursuing aggressive care, only to be met 
by a system that not only pays for that care but encourages it. In fact, we 
as primary-care physicians are not given the power or authority to slow 
the overuse of resources. Medicare encourages patients and families to be 
aggressive, and it pays specialists and hospitals generously to be aggressive; 
primary-care providers are often sidelined while needlessly aggressive care 
is administered.
It is thus not surprising that some of my most frail patients, and their 
families, often demand “thorough” care for many reasons. One is financial; 
as we will discuss, under Medicare’s rules it is often much less expensive 
for them to get aggressive medical treatment than to be conservative and 
compassionate, even if it costs Medicare substantially more and the out­
comes of such care may be worse. But just as important, many of my oldest 
patients, and their families who ultimately make the decisions about their
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welfare, believe in aggressive care. They have been inundated by the idea 
that more is better at any age, that numbers need to be fixed, that a cure 
is out there if only they pursue it. Even those who are skeptical are forced 
to live in a society where everyone else is telling them to be aggressive. 
When conservatives talk about death panels, and liberals declare that any 
restrictions on Medicare spending is akin to killing people, it is difficult for 
anyone to make rational decisions.
One of my good friends, a fellow geriatric physician, lamented to me 
the other day about a situation involving a patient of his, Mrs. L., who 
was far more ill than Mrs. A had been. She was old and had dementia, 
although independent until only recently when a series of medical insults 
had left her weak and confined to a nursing home. She now relied on kid­
ney dialysis and artificial food to keep her alive. My friend was appalled 
to learn that her family sought to pursue every option and treatment to 
maintain her life at all costs, even though several doctors had advised them 
otherwise. “She was living on her own just a few months ago,” her fam­
ily members said. My friend spent hours of unreimbursed time talking to 
doctors, reviewing notes, and reasoning with her children. But they perse­
vered. “She was living on her own just a few months ago.” They could not 
get past that fact. And the more my friend pushed to keep her comfortable, 
the more they resisted him. So they found a new doctor, one willing to per­
form dialysis on a woman who could no longer feed herself or talk, dialysis 
that is well reimbursed by Medicare. And they found a new nursing home 
willing to endorse their aggressive approach to care.
These were educated adult children. One was a nurse. But how little 
they understood the aging process, and how little they realized what older 
people really desire in their last months! Over 70 percent of elderly say 
they want to die at home, not in a hospital.19 But there is a very sharp 
divide between the more palliative approach that most elderly seek and 
how aggressively their families, doctors, and the system treat them.20 Many 
families are peering through a jaded lens. They love their mom so much 
that they just want to keep her alive and wish for a miracle, the miracle of 
reversing age and returning her to her healthy state when she lived alone. 
The illusion of turning back the clock with aggressive care is alluring but 
often deceptive. In the elderly, it only takes one illness to trigger a chain re­
action in the body that decimates it. Healthy three months ago and dialysis 
dependent now does not mean a mere blip has occurred. It is, rather, one of
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the consequences of aging, the end-stage of a process that was accelerating 
beneath the surface and then exploded to its tragic conclusion. But fantasy 
overtakes their thoughts. Medicare pays the bills. And their mom pays the 
price.
Many of my patients squander tens of thousands of Medicare dollars in 
their last months of life, clinging to a quixotic hope that cure is possible if 
they push hard enough and spend enough money. End-of-life expenses, in 
fact, are one of the primary drivers of medical costs for the elderly. Twenty- 
five percent of total Medicare expenses finance end-of-life care, care that 
accomplishes nothing but painfully prolonging the inevitable. Incredibly, 
with the endorsement of Medicare, the health-care profession unleashes 
the full force of its medical resources at problems that are not fixable and 
merely lead to death.21 While only a negligible amount of Medicare funds 
are spent on helping people like Mrs. A. stay comfortable in their home 
where they can receive appropriate medical care, Medicare spends a quar­
ter of its entire budget trying to save people who are not savable and who 
usually do not want to be “saved.”
Although a majority of elderly people want to die at home with com­
fort, only a fifth of them actually achieve that goal. Fifty percent die in 
a hospital, and 40 percent of those are in intensive care units where they 
will likely be sedated or have their arms tied down. Few elderly elect to be 
treated with such flagrantly ineffective aggression in their final days and 
months, but many forces, including the harsh reality of Medicare, push 
them where they do not want to be. Another 30 percent of the elderly die 
in nursing homes, often explicitly against their wishes, forced to bow to the 
financial realities of our current geriatric health-care system.22
In the following pages we will explore Medicare’s continued advocacy 
of aggressive medical care despite suffocating costs and poor outcomes 
from that approach, and will examine why Medicare seems unable to con­
trol that excess or redefine geriatric medical care so that it can sensibly ad­
dress the changing population that it serves. This book is not an assault on 
Medicare, which is an invaluable program that has transformed the care of 
our elderly, but rather is a critical analysis of how Medicare’s priorities may 
be leading to the very poor and expensive care that its reformers seek to 
change. As a primary-care doctor I am immersed in Medicare daily. I see 
how it impacts my ability to care for patients and my patients’ ability to ac­
cess the care they want for themselves. In fact, the very reason I wrote this
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book is because I value Medicare, and I seek to lend a voice to those who 
are calling for common-sense changes. As we will see, Medicare in its cur­
rent incarnation is both unsustainable and counterproductive in the quest 
to achieve the high-quality cost-effective health care that most doctors and 
their patients crave. Its reforms, many of which have driven doctors out of 
the system and which stymie my ability to care for my patients every day, 
are also leading us down a road no less rosy than the system they are trying 
to repair. In fact, to paraphrase an almost Orwellian zinger that distresses 
every primary-care doctor I know, we are now being implored to practice 
“quality” and “value” care using mechanisms that are the very antithesis 
of quality and value; the individuality of each patient is lost in the homog­
enization of health-care delivery that relies on quantifiable metrics that 
doctors must spend much of their time documenting in computers rather 
than looking patients in the eyes and having more meaningful conversa­
tions. If we are going to really cure Medicare, we must move our gaze to 
the doctor’s office and see how the current system and its complex array of 
reforms color the interaction between doctor and patient, between patient 
and the health-care-delivery system, between quality geriatric care and the 
realities of what Medicare offers its recipients. When we look at it in that 
context, I believe we are moving in a very dangerous direction, but one 
that can be easily righted with the input of doctors and patients rather than 
pundits and professional reformers.
Unless we curb the dangerous folly of aggressive care in our oldest res­
idents, unless we realize that with age comes a decline that no amount of 
dollars will curtail, unless we stop financing a medical quest that leads to 
nothing more than the very death it is attempting to stop, and unless we 
provide our elderly with the comfort and dignity that the vast majority 
of them seek, then Medicare will not persevere. Few of the innovations 
concocted by CMS or the Medicare reformers confront that reality. Few of 
them are proposing feasible means of helping Mrs. A.’s experience become 
the norm. But that should be our ultimate goal.
1D e fin in g  Q uality 
The Quest for Numerical Perfection
Everyone dies o f something. Every time a new complication develops, the 
doctor will assign it a name, giving you another diagnosis.. . .  Each diagnosis 
has a potential treatment, which the doctors will dutifully tell you about—  
if  you haven’t already looked it up on line.
Ira Byock, The Best Care Possible
The pharmaceutical industry has thrived in this country because peo­
ple believe that medicines are both essential and useful to repair a variety 
of dangerous and bothersome conditions, something that is especially true 
in the elderly. Whether treating aberrant numbers (blood pressure, cho­
lesterol, sugar, etc.) or helping to resolve nuisance conditions like urinary 
incontinence and confusion, drugs flood our elderly patients’ bodies. But 
many medications have dubious efficacy and can be frankly dangerous. 
Often they are used to treat problems that do not meaningfully improve, 
and more often they instigate troublesome symptoms, drug interactions, 
and harmful side effects.
Medicare does not itself compel patients to take more medicines; our 
national drug obsession is a much more complex phenomenon than can 
be ascribed simply to Medicare. But especially since the advent of Medi­
care D and the adaption of clinical performance measures (labeled as 
quality indicators by CMS) to grade doctor quality, Medicare is playing
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a larger role in encouraging and financing excessive medication use. 
And as we discussed, Medicare D places minimal restrictions on what 
drugs patients can take, and does not negotiate with pharmaceutical 
companies to secure medicines that are lower in cost but equally ef­
ficacious. Said one doctor who has studied this problem: “If the gov­
ernment’s real goal were to increase senior citizens’ access to the most 
effective medicine, its first step would have been to determine the best 
care based on the best scientific evidence available, helping patients and 
doctors to make informed decisions. Instead, the medicine prescription 
drug bill simply opens the public coffers to pay the price for expensive 
brand name drugs.”1
As significantly, Medicare as part of its reform effort is grading doctors 
based on the quality of their care, something that also can actually lead 
to more medication use. Through two programs primarily—the Physi­
cian Quality Reporting System (PQRS) and Accountable Care Organiza­
tions (ACOs), both of which we will discuss in detail later—Medicare is 
compelling doctors to produce evidence that they are following quality 
indicators as defined by CMS. We as physicians are required to complete 
an established set of questions, many of which have little relevance to our 
particular patients, and to demonstrate that we are in compliance with 
a variety of such indicators, something that will eventually help deter­
mine some of what we are paid. It is felt that such pay-for-performance 
strategies will help doctors practice better medicine and save the system 
money. It is a laborious and expensive process for us, and often it pushes 
us to mindlessly fill out scripted checklists when our time could be bet­
ter spent having meaningful discussions with our patients. Since every 
elderly patient has a unique set of wants and needs, and each one offers 
unique challenges that make templated responses virtually useless, Medi­
care’s attempt to impose quality standards on us yields more busywork 
than meaningful change.
Quality indicators have another dark side, one that can increase unnec­
essary testing and treatment in the elderly. By forcing us to comply with 
specific standards, Medicare expects us to order tests and prescribe drugs 
that we, and our patients, may not believe to be beneficial. By tying the 
quality of our care (and ultimately a portion of our salary) to the achieve­
ment of those standards, Medicare is pushing us to act in a way that may
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actually be counterproductive to quality care. Many indicators are de­
signed to persuade doctors to evaluate and treat abnormal numbers. High 
blood pressure, high cholesterol, high sugars, abnormal bone density re­
sults, low heart ejection fraction, irregular heart rhythms—all of these 
have specific guidelines that script what is deemed to be appropriate test­
ing and treatment. To be fair, many of Medicare’s quality indicators are 
more reasonable than other clinical-practice guidelines, many of which 
seek aggressive care for virtually every abnormal number in the elderly. 
But virtually none of Medicare’s quality guidelines encourage doctors to 
avoid testing for and treating these abnormal numbers even in the very 
oldest of our patients; at best, they encourage some testing and treating, 
and are silent about overtreatment. Just how important is it to treat ab­
normal numbers in the elderly? That is the crux of what we have to ex­
plore, for its answer illuminates much of what is wrong with Medicare 
and how to fix it.
Numbers
As an internal-medicine resident at the University of Virginia, I spent 
time in a rural clinic in Orange County working with two excellent doc­
tors. One day they sent me to see a farmer who was in his mid-90s and 
still worked his farm independently. When I saw the man he seemed 
strong and young, very calm, fairly sharp, and nimble on his feet. I ex­
amined him and found nothing particularly wrong except for his blood 
pressure, which was close to 220/110 from my recollection. To me this 
finding was startling. I rechecked it a few times, and the results did not 
change. The man took no medicines and had no serious medical prob­
lems. He felt very well.
I talked to one of the clinic doctors and insisted that we treat the man for 
his dangerously elevated blood pressure. We had all read the new SHEP 
(Systolic Hypertension in the Elderly) study that demonstrated the dan­
gers of high blood pressure in the elderly,2 and thus we needed to be more 
vigilant in treating pressure elevations among our older patients. The doc­
tor bucked, but I convinced him to allow me to use a very mild blood pres­
sure medicine, and the patient agreed. I told him I would go out there next 
week and check the pressure again. Well, next week never came. Several
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days after starting the medicine, the man died. Coincidence? Unlikely. 
My guess, now that I have more extensive real-life experience with the 
elderly, is that the man had very narrow arteries to his heart and brain and 
kidneys, and he needed every bit of that high blood pressure to keep the 
blood flowing to his vital organs. In fact, his body’s natural auto regulation 
system probably pushed that pressure up to keep him alive. When I gave 
him a pill to make his numbers look better, I unintentionally dismantled 
his body’s coping mechanism by decreasing that necessary pressure and 
thus instigated his demise.
This is not an isolated event. Number obsession has reached a fever 
pitch among the elderly and those who care for them. Numbers are every­
thing, even if we are not quite sure what those numbers should be for each 
individual. As one doctor states in his book on medical excess: America’s 
elderly know their numbers “and are hell bent to be normal.”3 It may be 
blood pressure, pulse, sugar, cholesterol, kidney function, bone density, 
thyroid level, blood count, vitamin levels; there are dozens of numbers that 
can be measured, fussed over, and fixed with medicines. As people age, 
their numbers deteriorate and diverge from what is deemed “normal”; the 
more we look, the more we will find, and the more medicine we will need 
to dispense to fix.
We know from science and experience that the aggressive treatment of 
numerical abnormalities in the elderly, especially in conditions like dia­
betes and hypertension, frequently causes side effects, worsening physical 
and mental function, and an impaired quality of life without extending 
lifespan or even preventing major adverse outcomes (such as strokes, heart 
attacks, and cancer) in a measurably significant way. Medicines can fix 
numbers, but rarely do they improve a geriatric patient’s life. In fact, the 
more we toss into an elderly body, the more interactions and complications 
will occur. As we will see, low numbers are typically much more immedi­
ately dangerous than high ones; I have seen many more people injured and 
even killed by aggressive treatment that drops their numbers than by be­
nign neglect. But such a reality does not deter the US medical community 
from employing an array of medications in pursuit of numerical perfec­
tion. If the lore of what defines quality medical care starts anywhere, it is 
in the theater of medications, where numbers are perceived to be beacons, 
pills are touted as saviors, and those who push the pills and fix the numbers 
are our medical saints.
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I am frequently told by my patients, and those caring for them, that I 
have to be more vigilant in monitoring and fixing numbers. Physical thera­
pists and home care nurses e-mail me about blood pressures or sugars that 
are too high; they often have an alarmist tone when they convey the in­
formation, expecting me to intervene quickly. Nursing homes, as we will 
see, measure and expect immediate treatment for an infinitude of num­
bers, from thyroid levels to blood pressures, sugars, and a large variety of 
labs. My patients see specialists, emergency room doctors, and even family 
members who frighten them about their abnormal numbers. Often these 
abnormal numbers are merely blips, the results of tests taken at inoppor­
tune times when patients are in pain, stressed, ill. Sometimes the numbers 
are not even very high, but they have crossed some imaginary line between 
normal and dangerous. The assumption by many who contact me is that 
once that line is crossed, then a stroke or heart attack or perhaps even death 
is imminent.
Since numbers can be easily measured, and since so many of them can 
be “fixed” with medicines, patients often swallow handfuls of pills to push 
their numbers back to the acceptable side of normal, after which they can 
be monitored in a variety of ways to ensure the numbers stay in line. And 
if the numbers start to migrate away from what we have deemed to be 
normal, more medicines and tests will naturally flow through their frail 
bodies. But what are normal numbers for the elderly, and does fixing ab­
normal numbers impart any meaningful clinical benefit to our patients?
We can measure numbers many ways. Tests, labs, vital signs: for every 
patient, we can compile numbers that come to define them. Then we label 
our patients with diseases that correspond to their errant numbers. They 
may have high blood pressure, high cholesterol, diabetes, osteoporosis, 
hypothyroidism, anemia, dementia, and one of any number of conditions 
that we can treat and then monitor through copious lifelong testing. In my 
practice the pursuit of numerical excellence is one of the primary reasons 
patients see me and an army of specialists on a regular basis. Many doctors 
who have studied our health-care system believe that the medical commu­
nity is intentionally manufacturing disease by using these numbers because 
the medical community thrives when more people are sick. Some state that 
we are turning aging itself into a disease.4 Locating a number that equates 
to an illness and that can be altered with medicine is seems to many people 
like a productive use of medical science these days.
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To best assess the value of measuring and improving numbers in our 
elderly patients we have only two tools: experience and scientific investiga­
tions. The former is a subjective means of assessment that doctors like me 
utilize based on what years of practicing medicine have taught us, while the 
latter is alleged to be more objective and universally applicable. The truth 
is that most studies done on medications do not involve older people, as el­
derly patients typically are excluded from medication studies.5 The studies 
that do have an older cohort rarely involve elderly participants on multiple 
medicines and with numerous medical problems resembling the major­
ity of older patients for whom I care. Also, most studies are sponsored by 
drug companies, and when the results of those studies diverge from what 
the pharmaceuticals desire, the studies are not published.6 Thus, when we 
assess the impact of disease and medication on older patients, we are using 
very little data that is reliable and meaningful.
When we do evaluate studies about numbers and the medicines used to 
treat those numbers, we must be aware of a very important nuance in the 
statistical presentation of data, something of which I have only recently be­
come aware in my medical career. Most studies report their results in terms 
of relative risi\ and benefit. Those numbers could seem very impressive and 
make a test or treatment appear much more significant than it really is 
clinically. Absolute risf{ and benefit, however, is a much more revealing 
number, although rarely reported in the press or medical literature. In 
addition, it is important that the endpoint of a study reveals a clinically 
significant result. For instance, we do not care if a certain drug improves 
someone’s number; we do care if the drug, by improving the number, helps 
them be healthier or live longer. Pharmaceutical companies that sell medi­
cines and sponsor studies, medical researchers who gain prominence from 
demonstrating significant findings from their studies, and even members 
of the medical community who seek justification for aggressively labeling 
and treating disease all rely on the allure of relative risk. A small risk to a 
patient who has an abnormal number (such as high blood pressure), or a 
small improvement in the patient’s health from fixing that number, can be 
magnified into what seems to be a huge benefit when results are conveyed 
by relative risk and benefit rather than absolute risk and benefit.
Consider that a lottery in this country has a huge payoff, and you learn 
diat there is a fivefold higher chance of winning if you buy a ticket in Ohio 
instead of Maryland, where you live. Is it worth flying to Ohio to buy some
24 Chapter 1
tickets? The relative chance of winning in Ohio is five times higher, or 500 
percent better, than if you purchase a ticket in Maryland, an impressive 
number and perhaps worthy of a plane ticket. That is relative benefit. But 
the absolute benefit is much less impressive. If the chance of winning in 
Maryland is one in ten million, and the chance of winning in Ohio is five 
in ten million, then the absolute benefit of traveling to Ohio is a four in ten 
million increased chance of winning, a much less appealing advantage. A 
five-times relative benefit is really a four-in-ten-million absolute benefit. 
Thus, although in medical literature we hear almost exclusively about the 
relative benefit and risk of certain medicines and treatments, that number 
typically obscures the more relevant truth revealed by absolute risk and 
benefit.
It is important, then, to evaluate certain clinical situations where med­
icines are used to fix abnormal numbers in the elderly and to ascertain 
whether, in absolute terms, such interventions are justified. We also need 
to determine whether the risks of treating those numbers in the elderly are, 
in absolute terms, of concern to us. Medicare and the ACA, among other 
groups, are trying to assess and grade physician quality by tying it to the 
measurement and fixing of numbers and various medical conditions. This 
is being touted as a major thrust of reform: paying doctors for quality per­
formance is perceived to be a revolutionary means of saving Medicare. But 
the validity of such an approach lies hidden in the numbers themselves. 
The question is: Can we achieve improved health-care outcomes in the 
elderly at a reduced cost by measuring and fixing numbers through models 
such as Medicare’s quality indicators? The answer to that question reveals 
a deeply rooted flaw in our geriatric health-care delivery system, a flaw 
that has blinded many of those who are now trying to reform Medicare, 
and one that we will explore throughout this book.
The Case of A-fib
Medicare Quality Indicators state that all people over age 18 who are deemed to 
be high nskjor strode by specified criteria [which include virtually all o f the el­
derly] should take Warfarin or a similar anticoagulant.1
The treatment of atrial fibrillation (A-fib) with warfarin (brand name 
Coumadin) is a good illustration of how relative risk can be a misleading
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means of evaluating a treatment. A-fib is a condition common in the el­
derly where the heart beats irregularly and rapidly. The primary difficulty 
with A-fib is that clots can accumulate in the heart and cause strokes. To 
prevent this complication, doctors place patients on blood thinners such 
as warfarin, an old rat poison that prevents clots from developing. In fact, 
people with A-fib on warfarin have 50 percent fewer strokes than do peo­
ple with A-fib on aspirin.8 Because of such impressive results, virtually all 
doctors recommend the use of warfarin in their older patients. Its use is 
standard care and it is part of every clinical performance measure to which 
doctors are supposed to adhere. For most of my career, I never questioned 
its unassailable necessity; after all, why risk a stroke when there is such an 
effective treatment available?
But numbers can be deceptive. Fifty percent reduction is a relative ben­
efit. In fact, the chance of an older person with A-fib getting a stroke is 
close to 6 percent a year. With aspirin that number moves down toward 
4 percent. With warfarin that number is closer to 2 percent.9 True, war­
farin confers a 50 percent risk reduction compared to aspirin, but that is 
because it cuts the risk of stroke in half compared to aspirin, reducing it 
from 2.5 percent with aspirin to 1.4 percent with warfarin.10 Also, as many 
as half the strokes that occur are minor and leave no lasting effects, so the 
clinically relevant improvement is half of those numbers, or a 6/1000 de­
crease in the number of disabling strokes in people who take warfarin in­
stead of aspirin. That is the absolute risk reduction. Looking at it another 
way, there is a 99.3 percent chance of averting a clinically relevant stroke 
with warfarin, and a 98.7 percent chance of averting a stroke with aspirin. 
When my patients hear about a 50 percent reduction in stroke, they are 
petrified about using aspirin instead of warfarin, despite their fears of war­
farin. When I tell my patients about the absolute risk reduction, however, 
many of them prefer to take their chances and use aspirin, especially my 
patients who are older and are on many other medicines.
Why not just use warfarin? Major strokes can be devastating, so even a 
small risk reduction can be significant. The problem is that warfarin is not 
a benign drug. It interacts with virtually every medicine and food, from 
tea, to Tylenol, to a dinner salad. Patients must check their blood levels 
frequently; failure to do so could result in either ineffective doses or toxic 
doses. Patients on warfarin bleed more, sometimes dangerously so, espe­
cially if they fall down, and especially if they are over eighty. Studies sug­
gest that the risk of serious bleeding ranges from 4 to 7 percent (40—70/1000)
